HIF 2 alpha (EPAS1) Human shRNA Plasmid Kit (Locus ID 2034)
CAT#: TG315484
EPAS1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 3 publications. |
Product images
经常一起买 (2)
EPAS1 mouse monoclonal antibody, clone OTI2G5 (formerly 2G5)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | HIF 2 alpha (EPAS1) Human shRNA Plasmid Kit (Locus ID 2034) |
Locus ID | 2034 |
UniProt ID | Q99814 |
Synonyms | bHLHe73; ECYT4; HIF2A; HLF; MOP2; PASD2 |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | EPAS1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 2034). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_001430, NM_001430.1, NM_001430.2, NM_001430.3, NM_001430.4, BC051338, BC051338.1, BC015869, BM671511, NM_001430.5 |
Summary | This gene encodes a transcription factor involved in the induction of genes regulated by oxygen, which is induced as oxygen levels fall. The encoded protein contains a basic-helix-loop-helix domain protein dimerization domain as well as a domain found in proteins in signal transduction pathways which respond to oxygen levels. Mutations in this gene are associated with erythrocytosis familial type 4. [provided by RefSeq, Nov 2009] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (3)
The use of this RNAi has been cited in the following citations: |
---|
Hypoxia regulates SOX2 expression to promote prostate cancer cell invasion and sphere formation
,null,
American Journal of Cancer Research
,PubMed ID 27294000
[EPAS1]
|
HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma
,null,
British Journal of Cancer
,PubMed ID 26439684
[EPAS1]
|
Modulation of the mevalonate pathway by Akt regulates macrophage survival and development of pulmonary fibrosis
,Larson-Casey, JL;Murthy, S;Ryan, AJ;Carter, AB;,
J. Biol. Chem.
,PubMed ID 25378391
[EPAS1]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...